Physician profile
Mark Dotson
NPI 1689642019
$1,066.62
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $130 · 2021: $35.47 · 2022: $261 · 2023: $159 · 2024: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $174.60 | 2019-2020 | |
| Abbvie INC. | $138.32 | 2022-2024 | Dalvance |
| Smith+Nephew, INC. | $102.21 | 2019-2023 | Stravix, Grafix, Oasis |
| Kowa Pharmaceuticals America, INC. | $92.10 | 2022-2023 | Seglentis |
| Horizon Therapeutics Plc | $89.64 | 2019-2022 | |
| Averitas Pharma INC. | $80.55 | 2023-2024 | Qutenza |
| Zyla Life Sciences, INC. | $74.25 | 2019-2020 | |
| Treace Medical Concepts, INC. | $48.82 | 2024 | |
| Kerecis Limited | $47.99 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.30 | 2021-2022 | |
| Innovation Technologies INC | $24.00 | 2024 | Irrisept |
| Stimwave Technologies Incorporated | $22.27 | 2022 | |
| Melinta Therapeutics, LLC | $22.19 | 2019 | |
| Nabriva Therapeutics, Plc | $21.58 | 2022 | |
| Medtronic, INC. | $21.02 | 2023 | Intellis Adaptivestim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $18.89 | 2019 | |
| Grt US Holding, INC. | $17.23 | 2022 | |
| Merck Sharp & Dohme LLC | $16.85 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dotson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.